- Home
- VIRC vs COEP Comparison
VIRC vs COEP Comparison
Compare VIRC & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VIRC | COEP |
|---|---|---|
| Founded | 1950 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 100.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VIRC | COEP |
|---|---|---|
| Price | $6.43 | $14.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 66.1K | ★ 99.0K |
| Earning Date | 12-08-2025 | 11-14-2025 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $201,942,000.00 | $500,996.00 |
| Revenue This Year | $0.81 | N/A |
| Revenue Next Year | $4.56 | N/A |
| P/E Ratio | $25.94 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.01 | $3.80 |
| 52 Week High | $12.09 | $21.41 |
Technical Indicators
Market Signals| Indicator | VIRC | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 40.50 | 45.37 |
| Support Level | $6.20 | $13.88 |
| Resistance Level | $6.49 | $15.12 |
| Average True Range (ATR) | 0.20 | 0.85 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 31.86 | 50.73 |
Price Performance
Historical ComparisonAbout VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.